ciclopirox has been researched along with sesquiterpenes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaumont, JP; Michel, L; Millet-Clerc, J; Yang, D | 1 |
| Becker, MW; Corbett, C; Guzman, ML; Hassane, DC; Jordan, CT; Sen, S | 1 |
1 trial(s) available for ciclopirox and sesquiterpenes
| Article | Year |
|---|---|
Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Cell Line, Tumor; Ciclopirox; Drug Synergism; Female; Humans; Leukemia, Myeloid, Acute; Male; Pyridones; Sesquiterpenes; TOR Serine-Threonine Kinases | 2013 |
1 other study(ies) available for ciclopirox and sesquiterpenes
| Article | Year |
|---|---|
Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis.
Topics: Animals; Antifungal Agents; Ciclopirox; Hoof and Claw; Humans; Imidazoles; Onychomycosis; Polycyclic Sesquiterpenes; Pyridones; Sesquiterpenes; Sheep; Trichophyton | 1999 |